Humanis Saglik Anonim Sirketi
Clinical trials sponsored by Humanis Saglik Anonim Sirketi, explained in plain language.
-
Generic diabetes pill put to the test against Brand-Name drug
Disease control CompletedThis study checked if a new generic pill for type 2 diabetes (ertugliflozin/metformin) works the same as the brand-name drug (Segluromet). Thirty-six healthy adults took a single dose of each pill in random order. The goal was to see if the body absorbs both drugs at similar leve…
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Generic diabetes combo pill put to the test
Disease control CompletedThis study compared a generic combination tablet containing three diabetes drugs (empagliflozin, linagliptin, and metformin) to the brand-name Trijardy XR. Fourteen healthy adults took a single dose of each under fed conditions to see if the generic is absorbed at the same rate a…
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Generic diabetes combo drug shows promise in healthy volunteers
Knowledge-focused CompletedThis study tested whether a generic version of the diabetes medication Synjardy XR (empagliflozin and metformin) works the same as the brand-name drug. Thirty-two healthy adults took a single dose of either the generic or brand tablet under fasting conditions. The goal was to see…
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Generic vonoprazan put to the test against Brand-Name voquezna
Knowledge-focused CompletedThis study compared a generic vonoprazan 20 mg tablet to the brand-name Voquezna in 28 healthy adults. Participants took a single dose of each under fasting conditions to see if the generic releases the same amount of drug into the bloodstream. The goal was to check bioequivalenc…
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Generic diabetes drug put to the test against Brand-Name synjardy XR
Knowledge-focused CompletedThis study checks whether a generic version of the diabetes drug empagliflozin/metformin works the same as the brand-name Synjardy XR. Forty healthy adults each take one dose of both pills under fed conditions, and researchers compare how much drug gets into the bloodstream. The …
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Generic schizophrenia drug shows promise in early test
Knowledge-focused CompletedThis study tested whether a generic version of the schizophrenia drug brexpiprazole works the same as the brand-name drug (Rxulti). Thirty-six healthy adults took a single dose of each version, and researchers measured drug levels in their blood. The goal was to see if the generi…
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Generic apixaban tablet tested against eliquis in healthy volunteers
Knowledge-focused CompletedThis study tested whether a generic version of the blood thinner apixaban (5mg tablet) works the same as the brand-name drug Eliquis. Thirty healthy adults took a single dose of each under fasting conditions, and researchers measured drug levels in their blood. The goal was to ch…
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:11 UTC
-
Generic cholesterol drug shows promise in early comparison
Knowledge-focused CompletedThis completed study tested whether a generic bempedoic acid tablet works the same as the brand-name drug Nilemdo in 32 healthy adults. Participants took a single dose of each under fasting conditions, and researchers measured drug levels in the blood. The goal was to see if the …
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:45 UTC